In this study, we found that the frequency of TP53 and DPP6 gene mutations in all lung cancer were higher than that of other genes, and the frequency of TP53 mutations in SCLC was particularly high (85.4%) and significantly higher than that in LUSC. The gene discussed is TP53; the disease is lung cancer.